Related Experiment Video
Updated: Feb 20, 2026

Measurement of Spatial Stability in Precision Grip
Published on: June 4, 2020
Does grip strength decrease in the very early stages of hematological treatment?
C G C Teodozio1, G V Chaves2, I P Arcuri3
1Program of Molecular Carcinogenesis, Brazilian National Cancer Institute, Andre Cavalcanti Av. 37, Rio de Janeiro, 20231-050, Brazil.
Abstract:
Muscle weakness in hematological cancer patients undergoing acute stages of treatment is an important concern and strong predictor of poor outcomes. However, evidence of strength loss in the very early stages of cancer treatment is not addressed. Here, we found that grip strength was compromised within the first 7 days of hematological treatment (- 2.3 kg, P = 0.002). These findings are novel in elucidating lower handgrip strength in the first week of hematological treatment and encourage additional research focusing on handgrip strength in oncology patients under initial high-dose chemotherapy routine.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Hemodialysis II: Procedure and Complications
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...

